Filtered By:
Condition: Anxiety
Therapy: Corticosteroid Therapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 95 results found since Jan 2013.
Long ‐term treatment outcomes in refractory rhinitis medicamentosa managed with nasal surgery
ConclusionSurgically re-establishing a nasal airway was associated with long-term decongestant cessation and symptom improvement in medically refractory RM.This article is protected by copyright. All rights reserved
Source: International Forum of Allergy and Rhinology - July 15, 2023 Category: Allergy & Immunology Authors: William Li,
Shibalik Misra,
Richard John Harvey,
Larry Kalish Tags: ORIGINAL ARTICLE Source Type: research
Hypereosinophilic syndrome in Europe: retrospective study of treatment patterns, clinical manifestations, and healthcare resource utilization
CONCLUSION: Patients with HES across five European countries had a substantial disease burden despite extensive OCS treatment, highlighting the need for additional targeted therapies.PMID:36863663 | DOI:10.1016/j.anai.2023.02.022
Source: Annals of Allergy, Asthma and Immunology - March 2, 2023 Category: Allergy & Immunology Authors: Jeremiah Hwee Lynn Huynh Shawn Du Namhee Kwon Rupert W Jakes Rafael Alfonso-Cristancho Lee Baylis Gema Requena Anamika Khanal Marc E Rothenberg Mei Sheng Duh Source Type: research
Severe Asthma Patients on Ways Their Doctors Could Improve Treatment
Approximately 25 million people in the U.S. have asthma, according to the Asthma and Allergy Foundation of America. While that number shows how common the condition has become, the severe form is more rare. An estimate from a September 2021 study in the Journal of Asthma and Allergy found that about 9% of people with asthma meet the criteria for severe asthma.
Severe asthma comes with significantly more challenges than regular asthma. People with this condition tend to experience more symptoms, including increased activity limitations, greater prevalence of heart disease, and lower lung function. Even with high doses of in...
Source: TIME: Health - February 7, 2023 Category: Consumer Health News Authors: Elizabeth Millard Tags: Uncategorized Disease healthscienceclimate Source Type: news
What to Know About Severe Asthma in Kids
Asthma isn’t always a quick and easy diagnosis in children. According to a 2014 task force assembled by the American Thoracic Society and the European Respiratory Society, pediatric severe asthma can be diagnosed if a child’s symptoms require treatment with high-dose inhaled corticosteroids plus a second “controller” medication for a full year, and/or systemic corticosteroids for half a year or longer. In other words, its diagnostic criteria are based on the intractability of its symptoms.
“It’s definitely a limitation when you’re defining a disease state based on how much medicine...
Source: TIME: Health - October 21, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Disease healthscienceclimate Source Type: news
Low-dose oral corticosteroids in asthma associates with increased morbidity and mortality
Conclusion
The study findings should be interpreted with their observational nature in mind. However, we found that even at low cumulative exposure, OCS use in asthma management was associated with increased risk of comorbidities, mortality and unscheduled hospital visits. Effective strategies for optimising asthma control and reducing OCS use are pivotal in asthma management.
Source: European Respiratory Journal - September 15, 2022 Category: Respiratory Medicine Authors: Skov, I. R., Madsen, H., Henriksen, D. P., Andersen, J. H., Pottegard, A., Davidsen, J. R. Tags: Asthma and allergy Original Articles: Asthma Source Type: research
Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician
CONCLUSIONS: While other respiratory viruses are known to cause qualitative olfactory disturbances, the incidence of parosmia following COVID-19 is notable, and correlates negatively with age. The presence of parosmia predicts persistent quantitative olfactory dysfunction. Onset can occur months after infection, and symptoms may persist for well over 7 months. Affected patients report increased anxiety and decreased quality of life. Structured olfactory training with essential oils is the preferred treatment, where parosmia predicts recovery of aspects of quantitative smell loss when undergoing training. There is limited e...
Source: American Journal of Rhinology and Allergy - August 12, 2022 Category: ENT & OMF Authors: Joseph B Gary Liam Gallagher Paule V Joseph Danielle Reed David A Gudis Jonathan B Overdevest Source Type: research
Clinical Characteristics and Disease Burden of Severe Asthma According to Oral Corticosteroid Dependence: Real-World Assessment From the Korean Severe Asthma Registry (KoSAR)
CONCLUSIONS: One-fifth of patients with severe asthma had OCS-dependency, which was associated with a greater disease burden compared to those with OCS-independent asthma. Active intervention including initiation of biologics and regular assessment of OCS-induced morbidities is warranted to reduce the use of OCS and its potential adverse effects.PMID:35837824 | DOI:10.4168/aair.2022.14.4.412
Source: Allergy, Asthma and Immunology Research - July 15, 2022 Category: Allergy & Immunology Authors: Ji-Hyang Lee Hyo-Jung Kim Chan Sun Park So Young Park So-Young Park Hyun Lee Sang-Heon Kim You Sook Cho Working Group on Severe Asthma, the Korean Academy of Asthma, Allergy and Clinical Immunology Source Type: research
